14q32 deletion syndrome: A clinical report

Clinical Dysmorphology

Volumn 21, Issue 1, 2012, Pages 42-44

  Youngs, Erin L ^a,b   Dasouki, Majed ^b   Butler, Merlin G ^a,b  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BICUSPID AORTIC VALVE; CASE REPORT; CHROMOSOME 14Q32 DELETION SYNDROME; CHROMOSOME ANALYSIS; CHROMOSOME DELETION; CHROMOSOME DUPLICATION; DEVELOPMENTAL DISORDER; ECZEMA; FACE DYSMORPHIA; FAILURE TO THRIVE; FEMALE; HEAD CIRCUMFERENCE; HEARING TEST; HUMAN; INTRAUTERINE GROWTH RETARDATION; KARYOTYPE 46,XX; LETTER; MICROARRAY ANALYSIS; NEWBORN; OLIGOHYDRAMNIOS; PATHOLOGICAL CRYING; PHENOTYPE; PREGNANCY; PRIORITY JOURNAL; STOMACH TUBE; STRABISMUS;

CHROMOSOME ABERRATIONS; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 14; FACIES; FEMALE; HUMANS; INFANT; VOICE DISORDERS;

EID: 83255187038     PISSN: 09628827     EISSN: 14735717     Source Type: Journal    
DOI: 10.1097/MCD.0b013e328348d8d0     Document Type: Letter

References (12)

1. Bejjani BA, Shaffer LG (2008). Clinical utility of contemporary molecular cytogenetics. Annu Rev Genom Hum Genet 9:71-86.
2. Butler MG, Fischer W, Kibiryeva N, Bittel DC (2008). Array comparative genomic hybridization (aCGH) analysis in Prader-Willi syndrome. Am J Med Genet A 146:854-860. (Pubitemid 351499789)
3. Edelmann L, Hirschhorn K (2009). Clinical utility of array CGH for the detection of chromosomal imbalances associated with mental retardation and multiple congenital anomalies. Ann NY Acad Sci 1151:157-166.
4. Fruhman G, Van den Vayver IB (2010). Applications of array comparative genomic hybridization in obstetrics. Obstet Gynecol Clin North Am 37:71-85.
5. Liang JS, Shimojima K, Yamamoto T (2008). Application of array-based comparative genome hybridization in children with developmental delay of mental retardation. Pediatr Neonatal 49:213-217.
6. Manning M, Hudgins L (2010). Array-based technology and recommendations for utilization in medical genetics practice for detection of chromosomal abnormalities. Genet Med 12:745-745.
7. Masurel-Paulet A, Andrieux J, Callier P, Cuisset JM, Le Caignec C, Holder M, et al. (2010). Delineation of 15q13.3 microdeletions. Clin Genet 78:149-161.
8. Miller DT, Adam AP, Aradhya S, Biesecker LG, Brothman AR, Carter NP, et al. (2010). Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet 86:749-764.
9. Ortigas AP, Stein CK, Thomson L, Hoo JJ (1997). Delineation of 14q32.3 deletion syndrome. J Med Genet 34:515-517. (Pubitemid 27268135)
10. Shinawi M, Cheung SW (2008). The array CGH and its clinical applications. Drug Discov Today 13:760-770.
11. Wilson RD, Blight C, Langlois S (2009). Diagnosing chromosomal abnormalities from big to small with molecular cytogenetic technology. J Obstet Gynaecol Can 31:414-421.
12. Youngs EL, Hellings JA, Butler MG. A clinical report and further delineation of the 14q32 deletion syndrome. Clin Dysmorph (2011) (in press)